v3.25.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating Activities:    
Net loss $ (85,682) $ (83,644)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 14,910 10,307
Amortization of intangible assets 2,677 2,678
Stock-based compensation expense, net of amounts capitalized 4,101 2,101
Allowance for expected credit losses (18) (55)
Inventory allowance (504) 1,664
Loss on disposal of property and equipment 27 1,652
Change in fair value of warrant liability 8,367 1,163
Paid-in-kind and accrued interest expense 25,267 23,271
Amortization of debt premium (3,661) 0
Amortization of debt issuance costs 2,100 6,300
Interest expense on financing obligation 458 523
Intangibles impairment 3,700 0
Changes in operating assets and liabilities:    
Accounts receivable (125) 1,090
Inventory 494 (4,002)
Prepaid expenses and other current assets 87 903
Other assets (32) (2,984)
Accounts payable (1,507) 5,110
Operating lease liabilities (4) (23)
Finance lease liabilities 47 21
Accrued liabilities 2,108 5,630
Net cash used in operating activities (27,190) (28,295)
Investing Activities:    
Purchases of property and equipment (12,071) (72,629)
Net cash used in investing activities (12,071) (72,629)
Financing Activities:    
Proceeds from issuance of Series A preferred stock, net of issuance costs 21,407 0
Proceeds from issuance of common stock, net of issuance costs 3,543 0
Proceeds from issuance of debt 10,468 90,851
Proceeds from issuance of convertible note, net of debt issuance costs 9,975 0
Payment of minimum employee taxes withheld upon net share settlement of restricted stock units (847) 0
Principal payment on finance lease liabilities (40) (15)
Net cash provided by financing activities 44,506 90,836
Net change in cash and cash equivalents and restricted cash 5,245 (10,088)
Cash and cash equivalents and restricted cash at beginning of period 7,466 16,895
Cash and cash equivalents and restricted cash at end of period 12,711 6,807
Reconciliation of cash, cash equivalents, and restricted cash from the Unaudited Condensed Consolidated Balance Sheets to the Unaudited Condensed Consolidated Statements of Cash Flows    
Cash and cash equivalents 6,199 317
Restricted cash 6,512 6,490
Total cash and cash equivalents and restricted cash as shown in the Unaudited Condensed Consolidated Statements of Cash Flows 12,711 6,807
Non-cash investing and financing activities:    
Conversion of Series A Preferred Stock to common stock 21,407 0
Accrued interest capitalized to debt 15,293 0
Purchases of property and equipment included in accounts payable and accrued liabilities 915 3,123
Transaction costs recorded to Preferred Stock included in accounts payable 469 0
Stock-based compensation capitalized to property and equipment, net 306 655
Deemed dividend to preferred stockholders 403 0
Interest capitalized to property and equipment, net $ 0 $ 10,460

Source

PDF HTML
10-Q Filing
ZIP HTML
XBRL